Circulating Extracellular Vesicles: An Effective Biomarker for Cancer Progression

被引:1
|
作者
Chatterjee, Madhura [1 ]
Gupta, Saurabh [2 ]
Nag, Sayoni [3 ]
Rehman, Ishita [4 ]
Parashar, Deepak [5 ]
Maitra, Arindam [1 ]
Das, Kaushik [1 ]
机构
[1] Natl Inst Biomed Genom, Biotechnol Res & Innovat Council, Kalyani 741251, India
[2] GLA Univ, Dept Biotechnol, Mathura 281406, India
[3] Brainware Univ, Dept Biotechnol, Barasat 700125, India
[4] Neotia Univ, Dept Biotechnol, Parganas 743368, India
[5] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2024年 / 29卷 / 11期
关键词
biomarkers; cancer biomarkers; circulating extracellular vesicles; clinical trials; extracellular vesicles; therapeutics; POTENTIAL DIAGNOSTIC BIOMARKERS; EXOSOME-MEDIATED TRANSFER; INTERCELLULAR COMMUNICATION; CELLS PROMOTES; MESSENGER-RNA; PROGNOSTIC BIOMARKER; SERUM EXOSOMES; MICROVESICLES; EXPRESSION; MECHANISM;
D O I
10.31083/j.fbl2911375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs), the ubiquitous part of human biology, represent a small heterogenous, membrane-enclosed body that contains a diverse payload including genetic materials in the form of DNA, RNAs, small non-coding RNAs, etc. mostly mirroring their source of origin. Since, a vast majority of research has been conducted on how nucleic acids, proteins, lipids, and metabolites, associated with EVs can be effectively utilized to identify disease progression and therapeutic responses in cancer patients, EVs are increasingly being touted as valuable and reliable identifiers of cancer biomarkers in liquid biopsies. However, the lack of comprehensive clinical validation and effective standardization protocols severely limits its applications beyond the laboratories. The present review focuses on understanding the role of circulating EVs in different cancers and how they could potentially be treated as cancer biomarkers, typically due to the presence of bioactive molecules such as small non-coding RNAs, RNAs, DNA, proteins, etc., and their utilization for fine-tuning therapies. Here, we provide a brief general biology of EVs including their classification and subsequently discuss the source of circulatory EVs, the role of their associated payload as biomarkers, and how different cancers affect the level of circulatory EVs population.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis
    Hasan, Reaid
    Zhao, Zhen
    Li, Yuanke
    Liu, Yanli
    Zhang, Yuanyuan
    Cheng, Kun
    JOURNAL OF CONTROLLED RELEASE, 2025, 380 : 269 - 282
  • [42] Extracellular vesicles in cancer progression: are they part of the problem or part of the solution?
    Scholl, Juliete Nathali
    Dias, Camila Kehl
    Muller, Laurent
    Battastini, Ana Maria Oliveira
    Figueiro, Fabricio
    NANOMEDICINE, 2020, 15 (26) : 2625 - 2641
  • [43] Extracellular Vesicles as Mediators of Nickel-Induced Cancer Progression
    Liu, Shan
    Ortiz, Angelica
    Stavrou, Aikaterini
    Talusan, Angela R.
    Costa, Max
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [44] Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression
    Lopez, Kassandra
    Lai, Seigmund Wai Tsuen
    Lopez Gonzalez, Edwin De Jesus
    Davila, Raul G.
    Shuck, Sarah C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [45] Protein cargo in extracellular vesicles as the key mediator in the progression of cancer
    Hanelova, Klara
    Raudenska, Martina
    Masarik, Michal
    Balvan, Jan
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [46] Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression
    Mittal, Sonam
    Gupta, Prachi
    Chaluvally-Raghavan, Pradeep
    Pradeep, Sunila
    CANCERS, 2020, 12 (12) : 1 - 16
  • [47] Protein cargo in extracellular vesicles as the key mediator in the progression of cancer
    Klára Hánělová
    Martina Raudenská
    Michal Masařík
    Jan Balvan
    Cell Communication and Signaling, 22
  • [48] Medium Extracellular Vesicles-A Qualitative and Quantitative Biomarker of Prostate Cancer
    Switonska, Milena
    Jarosz, Oliwia A.
    Szolna-Klufczynska, Dagmara
    Sierakowska, Katarzyna
    BIOMEDICINES, 2022, 10 (11)
  • [49] Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
    Chengliang Huang
    Sitong Liu
    Xiang Tong
    Hong Fan
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 171 - 183
  • [50] Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
    Huang, Chengliang
    Liu, Sitong
    Tong, Xiang
    Fan, Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 171 - 183